Vials of a Covid-19 vaccine candidate co-developed by CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. — China Daily pic via Reuters
KUALA LUMPUR, Aug 30 — CanSino and Sinovac vaccines will be used to step up vaccination in six states which have yet to achieve vaccinating 50 per cent of the adult population, said Science, Technology and Innovation Minster (Mosti) Datuk Seri Dr Adham Baba.
He said the country would be acquiring three million doses of CanSino vaccine which only required one dose up to the end of the year while the additional supply of six million doses of Sinovac vaccine is sufficient to achieve herd immunity.
“CanSino vaccine is a breakthrough in the view of the Prime Minister as we do not have to wait if there is delay by the supplier which we have made a manufacturing and supply agreement with them.
“CanSino can be used in areas which are difficult to reach and remote for two-dose vaccination,” he said after his first working visiting to the fill and finish factory of Solution Biologics Sdn Bhd (SolBio) for Convidicea CanSino vaccine in Bukit Jalil today. — Bernama